恩帕吉菲
医学
肾脏疾病
内科学
疾病
环境管理计划
糖尿病
重症监护医学
2型糖尿病
内分泌学
电子探针
化学
矿物学
作者
William G. Herrington,Natalie Staplin,Christoph Wanner,Jennifer B. Green,Sibylle J. Hauske,Jonathan Emberson,David Preiss,Parminder K. Judge,Kaitlin J. Mayne,Sarah Y A Ng,Emily Sammons,Doreen Zhu,Michael Hill,Will Stevens,Karl Wallendszus,Susanne Brenner,Alfred K. Cheung,Zhihong Liu,Jing Li,Lai Seong Hooi
标识
DOI：10.1056/nejmoa2204233
摘要
The effects of empagliflozin in patients with chronic kidney disease who are at risk for disease progression are not well understood. The EMPA-KIDNEY trial was designed to assess the effects of treatment with empagliflozin in a broad range of such patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
gexzygg
MMMMM
MchemG
不配.
唐泽雪穗
Luis
Virtual
非而者厚
带头大哥
忧心的曼凝
YifanWang
AireenBeryl531
null
Billy
核桃
plum
GingerF
scm
yydragen
jyy
皖公网安备34019202002308
